EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular and System-Level Characterization of MMP12 Suppression in Lung Cancer: A Combined Bioinformatics and Molecular Approach

Shriefa Almutairi iD, Rima Hajjo iD, Dima A Sabbah iD, Kamal Sweidan, Zainab Ahmed Rashid, Sanaa K Bardaweel iD

International Journal of Molecular Sciences · 06.12.2025 · 26 (24) · 11802

DOI: 10.3390/ijms262411802 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.12.2025. Verfasst von Shriefa Almutairi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman 11942, Jordan. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 12, Lung Neoplasms, Computational Biology, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research, University of Jordan, Deanship of Scientific Research, The University of Jordan, Deanship of Scientific Research at Al-Zaytoonah University of Jordan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer remains a major cause of cancer-related death, highlighting the need for new molecular targets and novel therapeutics. Matrix metalloproteinases are key regulators of invasion and microenvironment remodeling, and among them, matrix metalloproteinase-12 (MMP12) is a particularly attractive candidate whose network-level effects in cancer are still poorly defined. Herein, we applied an integrative strategy that combines bioinformatics methods with experimental validation in non-small cell lung cancer (NSCLC) cells. Protein–protein interaction (PPI) and pathway analyses of MMP12-regulated genes identified 113 downstream targets enriched in the extracellular matrix, PI3K–AKT, and immune pathways, from which an eight-gene panel (MMP12, CD44, ADAM9, NFKBIA, PSME3, SPARCL1, CCL15, and APOA1) was prioritized as a biomarker signature. Guided by these predictions, we screened a 31-compound MMP12 inhibitor library and selected five leads (C1, C7, C9, C10, and C15) for testing in H1299 cells, with C9 showing the strongest antiproliferative activity. These compounds showed antimigratory activity (C1 achieving a 90% inhibition of wound closure at its IC50 concentration), reduced clonogenic growth, cell cycle perturbation, and induction of apoptosis. Gene- and protein-expression analyses confirmed MMP12 suppression and modulation of the eight-gene panel. Upstream regulator predictions implicated reduced AKT signaling alongside an ADAM9-centered adaptive axis. Collectively, these findings highlight C1, C7, C9, C10, and C15 as promising MMP12 inhibitors, supporting their further development in preclinical lung cancer and nominating the eight-gene panel as a pharmacodynamic signature for MMP12-targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Matrix Metalloproteinase 12Lung NeoplasmsComputational BiologyCarcinoma, Non-Small-Cell LungMatrix Metalloproteinase InhibitorsHumansCell Line, TumorGene Expression Regulation, NeoplasticProtein Interaction MapsCell ProliferationSignal TransductionCell Movement

Stichwörter der Autor:innen

MMP12 inhibitionapoptosisbioinformaticscell cycle arrestcomputational chemical biologylung cancermetastasismigrationsignaling pathways

Substanzen

Matrix Metalloproteinase 12MMP12 protein, humanMatrix Metalloproteinase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman 11942, Jordan.
  • Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan.
  • Laboratory for Molecular Modeling, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Department of Chemistry, The University of Jordan, Amman 11942, Jordan.

ORCID-Profile: Shriefa Almutairi, Rima Hajjo, Dima A Sabbah, Sanaa K Bardaweel

Förderung

  • Deanship of Scientific Research, University of Jordan
  • Deanship of Scientific Research, The University of Jordan
  • Deanship of Scientific Research at Al-Zaytoonah University of Jordan
  • Deanship of Scientific Research at the University of Jordan

Zitieren

APA

Almutairi, S., Hajjo, R., Sabbah, D. A., Sweidan, K., Rashid, Z. A., & Bardaweel, S. K. (2025). Molecular and System-Level Characterization of MMP12 Suppression in Lung Cancer: A Combined Bioinformatics and Molecular Approach. International Journal of Molecular Sciences, 26(24), 11802. https://doi.org/10.3390/ijms262411802

Vancouver

Almutairi S, Hajjo R, Sabbah DA, Sweidan K, Rashid ZA, Bardaweel SK. Molecular and System-Level Characterization of MMP12 Suppression in Lung Cancer: A Combined Bioinformatics and Molecular Approach. International Journal of Molecular Sciences. 2025;26(24):11802. doi:10.3390/ijms262411802

BibTeX
@article{Almutairi2025,
  author = {Almutairi, Shriefa and Hajjo, Rima and Sabbah, Dima A and Sweidan, Kamal and Rashid, Zainab Ahmed and Bardaweel, Sanaa K},
  title = {Molecular and System-Level Characterization of MMP12 Suppression in Lung Cancer: A Combined Bioinformatics and Molecular Approach},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {24},
  pages = {11802},
  doi = {10.3390/ijms262411802}
}
Kostenlos starten →